Houston Roofing Contractor, Arnold Roofing and Construction, Strengthens Homes with Professional Roof Repair and Replacement Services

Houston, TX – Arnold Roofing and Construction continues to serve homeowners throughout Houston with trusted roof repair and replacement solutions designed to keep homes secure and structurally sound. With a focus on quality workmanship, transparent communication, and long-term value, the company has become a reliable choice for residential roofing needs across the region. Roof damage […]

Class Action Filing Announced by Pomerantz LLP Concerning Fluor Corporation – FLR

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under

Class Action Proceeding Begun by Pomerantz LLP Concerning C3.ai, Inc. – AI

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. ("C3" or the "Company") (NYSE:AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

/C O R R E C T I O N — Indigenous Services Canada/

In the news release, Red Sucker Lake First Nation celebrates grand opening of new school, issued 21-Oct-2025 by Indigenous Services Canada over PR Newswire, we are advised by the company that the “Quotes” section has been updated. The complete, corrected release follows: Red Sucker Lake First Nation celebrates grand opening of new school Indigenous Services

Class Action Filing Announced by Pomerantz LLP Against Cytokinetics, Incorporate – CYTK

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Class Action Reminder from Pomerantz LLP for Investors of LifeMD, Inc. – LFMD

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ:LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Class Action Filed Against Baxter International, Inc. (BAX) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173310&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Wesdome Gold Mines Announces Normal Course Issuer Bid

(TSX:WDO),(OTC US:WDOFF),(Other OTC:WDOFF), TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company“) is pleased to announce that Wesdome's board of directors has approved, subject to approval of the Toronto Stock Exchange (the “TSX“) the initiation of a Normal Course Issuer Bid (“NCIB“) to repurchase up

Pomerantz LLP Pursues Class Action Lawsuit Against Molina Healthcare, Inc. – MOH

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE:MOH).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Ongoing Investigation Into MoonLake Immunotherapeutics (MLTX): Contact Levi & Korsinsky About Potential Fraud

NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin

Scroll to Top